Pancreatic Cancer Research

Clinical trialPhase 2Unknown

Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer

Chemotherapy-based Split Stereotactic Body Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: Study Protocol of a Prospective, Single-arm Phase II Trial

NCT04289792↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Outcome unknown
Phase
Phase 2
Status
Unknown
Study type
Interventional
Start
9 May 2020
Expected end
9 May 2025
Enrollment
27 participants
Sites
1
Primary outcomes
Kaplan-Meier Estimate of Progression-Free Survival (PFS)
Sponsor
Other
Results posted
No
Last update
16 February 2023

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 19